Group 1: Acetylcholinesterase (AChE) inhibitors

Group 14: Nicotinic acetylcholine receptor (nAChR) channel blockers

Group 19: Octopamine receptor agonists

Group 2: GABA-gated chloride channel antagonists

Group 22: Voltage-dependent sodium channel blockers

Group 28: Ryanodine receptor modulators

Group 29: Chordotonal organ nicotinamidase inhibitors

Group 3: Sodium channel modulators

Group 30: GABA-gated chloride channel allosteric modulators

Group 33: Calcium-activated potassium channel (KCa2) modulators

Group 36: Chordotonal organ modulators – undefined target site

Group 4: Nicotinic acetylcholine receptor (nAChR) competitive modulators

Group 5: Nicotinic acetylcholine receptor (nAChR) allosteric modulators – Site I

Group 6: Glutamate-gated chloride channel (GluCl) allosteric modulators

Group 9: Chordotonal organ TRPV channel modulators